The small protein ubiquitin is often linked to substrates as a polymer. Such polymers vary in both linkage and length, which has important consequences for their function. Surprisingly, the mechanisms of ubiquitin-chain assembly are still not known. Deciphering them will shed light on why substrates differ in the extent and timing of polyubiquitin modification and how ancillary ubiquitination factors function.
As is true for other covalent protein modifications such as phosphorylation and acetylation, dynamic modification of proteins by ubiquitin or ubiquitin-like proteins (Ubls) enables reversible switches between different functional states (Pickart and Eddins, 2004; Varshavsky, 2005) . Ubiquitination can also irreversibly inactivate a protein by targeting it to the 26S proteasome for degradation. The nature of ubiquitin-induced functional states depends on whether a single ubiquitin or multiple ubiquitin molecules are attached to the protein. Multiple ubiquitins can be attached to a protein either by monoubiquitin addition to separate substrate sites or, more commonly, in the form of a polyubiquitin chain attached at a single lysine.
With the maturation of research in the ubiquitin field, a number of general principles have emerged about the enzymatic mechanisms of ubiquitin ligation to proteins. The discovery that ubiquitin molecules can be ligated to one another to form extended ubiquitin polymers on a protein substrate was an early milestone (Chau et al., 1989) . Ubiquitin polymers display specific amide (isopeptide) linkages between their ubiquitin units, which link the ε-amino group of a lysine of one ubiquitin to the C-terminal carboxyl group of the next ubiquitin in the chain. There are seven different lysines in ubiquitin that can potentially be used for ubiquitin-chain synthesis. Proteins bearing Lys48-linked chains of at least four ubiquitin molecules are generally good substrates for degradation by the proteasome (Thrower et al., 2000) . Other ubiquitin-ubiquitin linkages have also been documented, and these different chain topologies correlate with different functional outcomes. The best-studied alternative ubiquitin-chain type is the Lys63-linked chain. Attachment to such chains activates specific proteins for DNA repair, signal transduction, and endocytosis, among other functions, but Lys63-linked polyubiquitin-protein conjugates are not targeted by the proteasome (Pickart and Fushman, 2004; Sun and Chen, 2004) .
All this is fairly well established, as is the identity of the enzymatic machinery responsible for attaching ubiquitin to various protein substrates. The now well-known E1-E2-E3 trio of enzymes is responsible for activating and transferring ubiquitin to proteins (see Figure 1) . Additionally, many high-resolution three-dimensional structures of different E2 and E3 enzymes have been determined, and these have yielded many insights into the mechanisms of ubiquitin-protein attachment. However, despite these advances, and contrary to most textbook depictions, the fundamental mechanism(s) of ubiquitin-chain assembly remains unknown. The textbook version-which has not been proven incorrect-holds that ubiquitin molecules are added one at a time, first to the substrate protein and then to the distal end of the growing ubiquitin chain. This "sequential addition model" is outlined in Figure 2A .
In this brief review, I will discuss variations of this model that have been proposed in recent years, and I will also outline more radical departures from the standard sequential addition model. In truth, there are few published results that allow a clear choice between these different schemes. Deciphering the exact mechanisms of ubiquitinchain assembly will be necessary for understanding many key features of protein ubiquitination, such as the apparent processivity of protein polyubiquitination, the activity of so-called chain elongation factors, and the shielding of polyubiquitin-protein conjugates from premature deubiquitination by cellular deubiquitinating enzymes (DUBs).
The Molecular Players in Ubiquitin-Chain Assembly and Disassembly Attachment of ubiquitin to substrate proteins involves several enzymatic steps (Pickart and Eddins, 2004) (Figure  1 ). The C terminus of ubiquitin is first activated by ubiquitin-activating enzyme (E1). Through an ATP-dependent mechanism, ubiquitin is coupled to a cysteine side chain in E1, yielding a reactive E1~ubiquitin thioester intermediate. The activated ubiquitin is subsequently passed to one of a number of distinct ubiquitin-conjugating enzymes (E2s) by transthiolation to a conserved cysteine of the E2. The E2 proteins catalyze substrate ubiquitination in conjunction with a ubiquitin-protein ligase (E3). For one structural class of E3 proteins (the "HECT" E3s), the ubiquitin is first transferred to a conserved cysteine of the E3 before the final transfer to a substrate group (usually a lysine side chain; Figure 1 ). For most other ubiquitination reactions, the E3 appears to function as an adaptor that positions the substrate in close proximity to the reactive E2~ubiquitin thioester bond. The majority of such E3s have a subunit or domain bearing a RING motif.
In addition to substrate recognition, other roles for E3s in the catalytic cycle, such as allosteric activation of the E2, remain a distinct possibility (Wu et al., 2003; Pickart and Eddins, 2004) . All E2s have an asparagine residue upstream of the active-site cysteine. This asparagine appears to help form the oxyanion hole that stabilizes the tetrahedral intermediate resulting from nucleophilic substrate attack on the activated ubiquitin carbonyl (Wu et al., 2003) . However, in the atomic structures of isolated E2 enzymes, the side chain of the asparagine is fully hydrogen bonded and oriented away from the active cysteine. E3 binding to the E2 or ubiquitin thioester formation on the E2 (or both) might trigger local structural changes that allow movement of the E2 asparagine side chain to a position where it can help generate a functional oxyanion hole (Reverter and Lima, 2005) .
Not to be forgotten are the DUBs. These enzymes have a major impact on cellular amounts of polyubiquitin chains, both those that are attached to specific proteins and those that are apparently unanchored or "free." The mechanistic characteristics of chain assembly, such as the degree of processivity, will influence the susceptibility of ubiquitinmodified proteins to deubiquitination. There are at least five different structural classes of DUBs, and a wide range of substrate specificities and functions have been reported (Amerik and Hochstrasser, 2004; Nijman et al., 2005) .
Coupling Ubiquitin Binding Sites for UbiquitinChain Assembly
When considering mechanisms of chain assembly, it is important to bear in mind that substrates are often adorned with very long ubiquitin polymers, sometimes containing over a dozen ubiquitin molecules (Varshavsky, 2005) . Another relevant fact is that free ubiquitin chains can be synthesized by some E2s without the aid of an E3. The earliest and most studied example is E2-25K, a mammalian E2 capable of assembling Lys48-ubiquitin chains (Chen et al., 1991) . Interestingly, E2-25K from mammals and Ubc1 from yeast include C-terminal domains related in structure to the UBA domain, which forms a three-helix bundle that binds ubiquitin (Merkley et al., 2005) . In neither case is the UBA domain required for free polyubiquitin-chain synthesis; however, deletion of the UBA of Ubc1 alters the length and ubiquitin-ubiquitin linkage specificity of the chain (Pichler et al., 2005; Merkley et al., 2005) . Thus, noncovalent binding of a second ubiquitin molecule to a separate site in the E2 might dictate certain features of ubiquitin-chain assembly. In other pathways, the E3 might provide this additional noncovalent ubiquitin binding site. This could place a second ubiquitin molecule near the ubiquitin~E2 thioester in a way that facilitates their linkage. Another way to juxtapose a pair of ubiquitin molecules for ubiquitin-ubiquitin formation might be through dimerization of E2s (Silver et al., 1992; Chen et al., 1993; Gazdoiu et al., 2005) . Most E2s behave in vitro as monomers, but both in vitro and in vivo analyses have suggested an ability to form dimers, particularly if the E2 is charged with ubiquitin. For the synthesis of Lys48-ubiquitin chains in vivo, E2 homodimers and heterodimers may be important in particular ubiquitination pathways. Homodimerization of the Cdc34 E2 is induced by ubiquitin thioester forma- Activation of the ubiquitin C terminus by E1 proceeds in two steps: adenylation (not shown) followed by attack by a cysteine side chain to form a thioester bond between the E1 and ubiquitin. Ubiquitin is then passed to a cysteine of an E2. Ligation of the ubiquitin to a substrate (S), usually to a lysine side chain, follows either directly with the aid of a RING-bearing E3 or after an intermediate transthiolation to a cysteine side chain of a HECT-domain E3. Both types of E3 interact with their substrates, many of which acquire a polyubiquitin chain rather than just a single ubiquitin. Note: The dashed red arrows represent the direction of movement of ubiquitin, not the direction of nucleophilic attack. tion and is necessary for its function (Varelas et al., 2003) , and heterodimer formation between the Ubc6 and Ubc7 E2s was suggested by yeast two-hybrid analysis (Chen et al., 1993) .
Perhaps the clearest data on the initiation of ubiquitinchain assembly comes from the structural analysis of the heterodimer formed between Ubc13 and UEV (ubiquitin-E2 variant) proteins, which specifically catalyzes Lys63-linked ubiquitin-chain synthesis (Pickart and Eddins, 2004) . The UEV proteins have the same overall tertiary structure as active E2 enzymes, but they lack the catalytic cysteine. Instead, the UEV protein positions a second ubiquitin molecule noncovalently in the Ubc13-UEV heterodimer such that Lys63 of the noncovalently bound ubiquitin can attack the thioester-linked ubiquitin on Ubc13. The structural data can neatly explain the topological specificity of ubiquitin dimer assembly by Ubc13-UEV heterodimers but do not clarify how longer chains are made.
Another significant point to consider in relation to ubiquitin-chain assembly mechanisms is the discovery that E1 and E3 binding sites on the E2 overlap, and their binding to E2 is mutually exclusive (Eletr et al., 2005) . Therefore, if ubiquitin chains are assembled on substrates by a sequential addition mechanism, multiple cycles of E2-E3 binding and release are probably necessary. Potentially, if a stable E2 dimer is present in the E2-E3 complex, full release of the E3 from the E2 might be avoided if E1 and E3 bind to different E2 monomers in the dimer. Other mechanisms of ubiquitin-chain synthesis might also require cyclical release of E2 from E3 (see below).
Who's on First: Models for Ubiquitin-Chain Assembly The sequential addition model (the standard model) for chain assembly is a logical extension of a monoubiquitination reaction in which a substrate lysine attacks the ubiquitin~E2 (or ubiquitin~HECT E3) thioester bond (see Figure 2A ). In each ensuing cycle, the ubiquitin most distal in the chain from the substrate provides the attacking lysine. This model becomes less intuitively appealing when applied to substrates with long ubiquitin chains because the attacking ubiquitin group becomes structurally remote from the original substrate protein bound to E3. This could be accommodated by looping out the growing ubiquitin chain between the substrate and E2 binding sites on the E3. Because E1 and E3 binding to an E2 appears to be mutually exclusive, such looping would need to be reestablished in each ubiquitin addition cycle if continuous E3-substrate binding is required for processive ubiquitination (Reiss et al., 1989; Rape et al., 2006) .
Several variations of the sequential addition model have been put forward. One idea, called the "hit-andrun" hypothesis, proposes that the ubiquitin~E2 thioester dissociates from the E3 and diffuses to the distal end of the growing ubiquitin chain, where ubiquitin transfer then occurs (Deffenbaugh et al., 2003) . This model is based on the observation that the E2 (Cdc34) must be released from the E3 (SCF Cdc4 ) for efficient substrate polyubiquitination.
However, this requirement might simply reflect the competition between E1 and E3 for overlapping binding sites on the E2. On the other hand, if the E3 triggers an activating conformational change in the ubiquitin~E2 complex prior to release, the hit-and-run model could still potentially explain how an E3 stimulates polyubiquitin-chain extension on a substrate. The Lys48 linkage specificity of these chains would have to derive from an intrinsic property of the Cdc34 E2. Another hypothesis that has been proposed to help explain the synthesis of long ubiquitin chains in the context of the sequential addition model invokes chain elongation factors (sometimes called "E4s") (Koegl et al., 1999) . These elongation factors still require an E3 of the HECT class for chain assembly. Although the exact mechanism by which they enhance long ubiquitin-chain assembly remains obscure, the proteins proposed to be E4s can themselves function as E3s in other assays (Hatakeyama et al., 2001 ). The E4 proteins contain a U box motif, which turns out to have a tertiary structure very similar to that of the RING domain (Ohi et al., 2003) . It is therefore plausible that E4 elongation factors are actually E3s that can use the ubiquitin thioester-linked HECT domain of their cognate E3s in much the same way that other E3s use a cognate ubiquitin~E2 thioester for chain elongation. As will be discussed below, chain "elongation factors" can be incorporated into other chain-assembly models as well.
What are the alternatives to the sequential addition model? Surprisingly few explicit discussions of polyubiquitin-chain-assembly mechanisms exist in the literature. The few exceptions usually only consider formation of the first ubiquitin-ubiquitin bond, which allows the more complicated gymnastics of long ubiquitin-chain synthesis to be side-stepped. One early idea, developed from the finding that unanchored ubiquitin chains can be synthesized de novo and can serve as donors for transfer to a (nonubiquitin) substrate (Chen et al., 1991; Van Nocker and Vierstra, 1993) , was that ubiquitin chains could be plucked from solution by an E1, and the available C-terminal carboxyl group at the base of the chain could then be activated and conjugated to a substrate. Most cell types have significant amounts of what appear to be "free" ubiquitin chains, so this idea is not entirely implausible (Van Nocker and Vierstra, 1993) .
Noel and colleagues recently proposed an "indexation model" for ubiquitin-chain synthesis (Verdecia et al., 2003) . Although highly speculative, this model was the first to address how a longer ubiquitin chain might be built on an enzyme active site prior to direct transfer to a substrate lysine (see Figure 2B) . The model was inspired by the observation that in HECT E3s, the HECT domain has two lobes connected by a flexible linker; flexibility in this hinge is essential for E3 activity. In the indexation model, sequential transfer of ubiquitin units from the E2 active site to the distal end of a ubiquitin chain tethered to the E3 cysteine would be marked by a progressive opening of the hinge between the two HECT domain lobes. A length limit to the chain is implied by this mechanism, and once a ubiquitin tetramer formed on the HECT active site, it was proposed that a substrate lysine would attack the thioester and acquire the ubiquitin chain. The existing literature, however, offers no evidence for such a chain length limit.
Alternatives to both the sequential addition and indexation models can be proposed. In what I will call the "seesaw model," a polyubiquitin chain is also assembled by a pair of active sites prior to transfer to substrate; these sites are assumed to arise from an E2 dimer, although an E2-HECT domain pairing is also possible (see Figure 2C ). The ubiquitin chain is built by a back-and-forth transfer of the growing ubiquitin chain from one active-site cysteine to the other. Chain transfer (as shown in Figure 2C ) is caused by nucleophilic attack on the thioester-linked carbonyl of one ubiquitin by a lysine side chain of the other thioester-linked ubiquitin. Another possible step in the cycle (not depicted in Figure 2C ) would be a transfer of the extended ubiquitin chain back to the other E2 cysteine by transthiolation. This would mean that only a single E2 in the dimer is charged by the E1 in all the ubiquitin addition cycles. At some point, a substrate lysine will attack the thioester at the base of the chain, resulting in substrate polyubiquitination. If substrate bound E3 specifically stimulated the ubiquitin-chainforming activity of the E2, then ubiquitin chains would be assembled preferentially when a substrate is available for subsequent modification by the chain. This might also limit E2 autoubiquitination and inactivation.
The seesaw and indexation mechanisms differ in several key regards. First and most importantly, in the seesaw mechanism, the latest ubiquitin added is always at the base of the chain rather than the distal end. Second, there is no obvious length limit imposed by this mechanism. Finally, if the ubiquitin chain is not returned to one of the E2s by transthiolation in each ubiquitin addition cycle, then E1 must alternate between charging different E2 monomers with ubiquitin, whereas in the indexation model, a single E2 suffices. (If an E2-HECT E3 dimer were the basis of the seesaw mechanism, either another E2 would be needed to charge the E3 or the ubiquitin chain would have to be moved by transthiolation to the E3 cysteine in each cycle.) Of all the models discussed in Figure 2 , only the seesaw mechanism always places the most recently added ubiquitin at the base of the chain, a feature that can be tested experimentally.
A final model to consider here is the "hybrid model" diagrammed in Figure 2D . In this scheme, a second, noncovalent ubiquitin binding site is supplied by an E2, E3, or another protein. The model is a hybrid because, as in the sequential addition mechanism, the noncovalent ubiquitin binding site is acting much like a RING E3 to position substrate-in this case ubiquitin-to facilitate nucleophilic attack on the ubiquitin~E2 thioester, but, as in the indexation/seesaw models, the polyubiquitin chain is linked to an enzyme active site prior to transfer to substrate. Cycles of ubiquitin-chain release and rebinding might be necessary for chain synthesis by this mechanism. Several results can be cited in support of the hybrid model. As noted earlier, ubiquitin-chain assembly by Ubc13-UEV heterodimers involves the positioning of a noncovalently bound ubiquitin for attack on a thioester-linked ubiquitin. The ubiquitin binding UBA domains of E2s such as E2-25K and Ubc1, though not necessary for ubiquitin-chain elongation, might function in the switch that moves the ubiquitin chain onto the E1 active-site cysteine ( Figure 2D) , from which the chain can be transferred to the E2 and then substrate. Some E3s also include ubiquitin binding domains, although their functional significance for polyubiquitin-chain synthesis is not certain.
Are there any experimental findings that lend credence to any of these alternative models? The answer, at present, is very few. However, in a study just published, Wang and Pickart (2005) provide the first experimental evidence for ubiquitin-ubiquitin bond formation between two ubiquitin molecules that must both be in thioester linkage to an active-site cysteine. When E6-AP, a monomeric HECT-class E3, carries a ubiquitin on its active-site cysteine, Lys48 of this ubiquitin attacks the ubiquitin thioester bond on the cognate E2. Assembly of a thioester-linked ubiquitin dimer on the HECT E3 is the same in the indexation and seesaw models, so distinguishing between these models will require analysis of longer ubiquitin chains. Unfortunately, E6-AP is inefficient in vitro at synthesizing chains with more than two ubiquitin moieties. Another interesting finding from this same study is that another HECT E3, KIAA10, uses a different mechanism of chain synthesis, which is most consistent with the sequential addition or hybrid model. Therefore, different E3s can utilize different mechanisms of polyubiquitin-chain assembly, at least in vitro.
Figure 2. Models for Polyubiquitin-Chain Synthesis
(A) Sequential addition model (the "standard model"), in which ubiquitin molecules are added one at a time, first to a lysine on the substrate protein (S) and then to a specific lysine in the ubiquitin at the distal end of the growing ubiquitin chain. A RING E3 is depicted and is assumed to remain associated with the substrate through multiple rounds of ubiquitin addition. (B) Indexation model (Verdecia et al., 2003) . The ubiquitin chain is first built on the active-site cysteine in the HECT domain of the E3 ligase before ultimately being transferred to the substrate. A flexible hinge between two lobes of the HECT domain (not depicted) allows repositioning of the ubiquitin chain such that a lysine in the distal end of the chain is oriented for attack on the E2~ubiquitin thioester. The chain is "indexed" to a limited length because of the physical constraints imposed by the E3 structure. (C) Seesaw model. Ubiquitin chains are built by a pair of E2s (either a homo-or heterodimer), which pass the growing chain back and forth between the two E2 active sites, before being transferred to the substrate. During chain assembly, the attacking lysine is always on a monomeric ubiquitin that is in thioester linkage to an E2. An E3 HECT domain could replace one of the E2s in this model. The order of ubiquitin addition is opposite to that in the other three models (compare colors). (D) Hybrid model. The ubiquitin chain is assembled prior to transfer to the substrate, but a noncovalent interaction between (poly)ubiquitin and a site in the E2 or E3 (the latter is depicted) positions it for nucleophilic attack on the E2~ubiquitin thioester, much as in the sequential addition model. At some point, the free end of the ubiquitin chain must be activated by E1 and transferred to the E2 cysteine before the final transfer of the chain to the substrate.
Implications of Different Chain-Assembly Models
How might these alternative ubiquitin-chain-assembly mechanisms impact our understanding of other features of ubiquitin-protein conjugation? One important parameter of protein polyubiquitination is the processivity of ubiquitin-chain formation (the number of ubiquitin molecules attached in one binding event to the E3). A more distributive mechanism of ubiquitin-chain assembly, where the ubiquitinated substrate intermediates dissociate from and must rebind the E3, presumably both limits the rate of longchain assembly and exposes the chains to disassembly by DUBs. By the sequential addition model, slower dissociation of a substrate from an E3 would enhance longubiquitin-chain assembly by increasing the probability of further ubiquitin additions before substrate dissociation. In contrast, by the models involving preassembly of ubiquitin chains on the E2 or E2-E3 complex, apparent processivity could be enhanced if nucleophilic attack by the substrate were delayed; this would allow further rounds of ubiquitinchain extension before transfer to the substrate. One implication of this reasoning is that two substrates with similar dissociation rates from an E3 might nonetheless have different propensities to form long ubiquitin chains because of structural differences that control substrate attack on the polyubiquitin~enzyme thioester. If their conjugate forms were targets of the proteasome, these substrates could have very different half-lives.
An elegant study in this issue of Cell (Rape et al., 2006) suggests that the degree of processivity in ubiquitin-chain assembly is substrate specific and can be exploited by the cell to dictate the temporal sequence in which multiple substrates of the same E3 are degraded. The E3 in this case is the anaphase-promoting complex (APC), a multisubunit complex with a RING-bearing subunit, which promotes the sequential degradation of several key cellcycle regulators during mitosis and G1. Highly processive substrates acquire long ubiquitin chains in vitro at the expense of more distributive substrates, which require multiple APC binding events for long-chain acquisition and are susceptible to deubiquitination. Notably, the temporal sequence in which APC substrates are degraded in vivo correlates with the relative processivity of their polyubiquitination by the APC.
Are these new data compatible with preassembly of ubiquitin chains or only with the sequential addition model? The authors argue in favor of the latter mechanism because they observed a gradual increase in polyubiquitin-protein conjugate size with time when a distributive substrate was analyzed, which seems contrary to the transfer of a single preassembled chain. Also, when they monitored single APC binding events with such a substrate, only a few ubiquitins were added to different substrate lysines, rather than polyubiquitin chains (Rape et al., 2006) . However, if apparent processivity is enhanced, as just discussed, by limiting the rate of ubiquitin transfer from the E2-E3 complex to substrate relative to the rate of assembly of a preformed chain on the E2, then these observations are in accord with what would be expected for a distributive substrate bearing multiple lysine targets. Preincubation of E1, E2, E3, and ubiquitin prior to substrate addition also did not enhance subsequent polyubiquitination of the substrate, as might have been expected if chains were preassembled on the E2 (Rape et al., 2006) . However, this result could also be accounted for if substrate binding to the E3 was necessary for stimulating ubiquitin-chain synthesis on the cognate E2, as suggested above, or if the E2 was autoubiquitinated and inactivated during the preincubation. The point is not that the sequential addition mechanism does not operate here, but rather that determining a particular chain-synthesis mechanism will generally require assays that specifically distinguish among the different mechanisms. In fact, an interesting possibility would be that "distributive" substrates are polyubiquitinated by a sequential addition mechanism, whereas "processive" substrates are able to engage the APC-E2 complex in a way that allows a more efficient preassembled chain-transfer mechanism.
Ubiquitin-chain synthesis was also addressed in another recent study, in this case using the in vitro system based on the SCF Cdc4 E3 and Cdc34 E2 (Petroski and Deshaies, 2005) . These authors reported that the attachment of the first ubiquitin to a substrate appears to be rate limiting for substrate polyubiquitination. The most direct evidence for this came from a comparison of an already monoubiquitinated substrate to the unmodified version of the same protein: the former is polyubiquitinated much more quickly than the latter. When looking at unmodified substrate, E3 stimulates both mono-and polyubiquitination with comparably slow kinetics. These results were interpreted in terms of the sequential addition model, in which the slow step in substrate polyubiquitination was the attachment of the first ubiquitin followed by rapid serial extension of the polyubiquitin chain. If one were to look at these data from the vantage of ubiquitin-chain preassembly, a slightly different interpretation could be proposed. The similar kinetics of monoubiquitination and polyubiquitination are consistent with an equally probable transfer of either a single ubiquitin or a preformed ubiquitin chain to the substrate. Provision of an already monoubiquitinated substrate simply creates a different substrate, and preassembled chains might preferentially transfer to such a substrate.
Chain elongation factors (E4s) can also be viewed in a different light if chain assembly proceeds through a seesaw or indexation mechanism. An E4 might function by altering the E2-E2 or E3-E2 complex, for example, to limit ubiquitin-chain hydrolysis from the active site or to accommodate a longer ubiquitin chain, so that longer ubiquitin chains are favored. Alternatively, an E4 might act as a processivity factor by decreasing the rate of whole-chain transfer to substrate relative to the rate of chain elongation on the E2 or E3. In a similar vein, the function of an E3 might include organizing or stabilizing an E2 dimer or E2-HECT domain interaction in a way that facilitates ubiquitin-chain elongation at the active sites of these enzymes. A recently solved crystal structure of an E2-E3 complex with a bound Ubl-substrate conjugate indeed suggests such a role for the E3 in correctly orienting a charged E2 (Reverter and Lima, 2005) .
Another potential consequence of assembling long ubiquitin chains on an E2 or E3 active site is the opportunity for self-regulation by autoubiquitination (and proteasomal degradation). Autoubiquitination of E2s has in several instances been shown to depend on the active-site cysteine, and the E2 cannot be polyubiquitinated in trans by another, active version of the same E2 (Rape and Kirschner, 2004; Walter et al., 2001) . The detected polyubiquitin chains on the E2 were lysine linked, but it is conceivable that a polyubiquitin chain on the E2 active-site cysteine could also target the protein to the proteasome. For UbcH10, a cell-cycleregulated E2 that functions with the APC E3, autoubiquitination only occurs after other APC substrates have been ubiquitinated and degraded in early G1 phase (Rape and Kirschner, 2004) . Degradation of UbcH10 is needed for the subsequent entry of cells into S phase.
Concluding Remarks
Although multiple E2 and E3 enzyme structures have now been determined, it is becoming apparent that many of these structures, particularly those of E2-E3 complexes, may be in conformations or arrangements that do not reflect the catalytically active state. For example, the distance between the E2 and E3 active-site cysteines observed in the UbcH7-E6-AP crystal structure is over 40 Å, even though ubiquitin transfer between these sites requires that they come within a few Ångstroms of one another (Huang et al., 1999) . A full understanding of how these E2-E3 complexes function will require that we figure out what the active subunit arrangements are (for example, must the complexes or at least the E2 components dimerize?) and by what mechanism polyubiquitin chains are assembled. This in turn will depend on well-defined in vitro systems for biochemical and kinetic studies. The first stirrings of work in this direction are emerging, and we should soon see the types of mechanistic models for ubiquitin-chain assembly outlined here put to rigorous test.
